Sun Pharmaceutical Industries informs about press release

26 Jul 2024 Evaluate

Sun Pharmaceutical Industries has informed that the company (which includes its subsidiaries and associate companies, ‘Sun Pharma’) has received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI™ (deuruxolitinib), an Oral JAK Inhibitor for the treatment of severe alopecia areata. A copy of the press release on this update is enclosed, and it shall be released after submitting this intimation.

The above information is a part of company’s filings submitted to BSE.


Sun Pharma Inds. Share Price

1749.50 -10.45 (-0.59%)
27-Nov-2024 11:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1749.50
Dr. Reddys Lab 1200.75
Cipla 1474.35
Lupin 2022.05
Zydus Lifesciences 952.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.